Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Reform proposals

Article Abstract:

Consumers and some members of congress are calling for greater government oversight of drugs already on the market following the harmful revelations of many of the FDA-approved drugs. Michael Leavitt, the secretary of Health and Human Services (HHS), states that the department needs to move in a direction in order to monitor the drugs after its approval to the market.

Author: Ferris, Marc
Publisher: Congressional Quarterly, Inc.
Publication Name: CQ Researcher
Subject: News, opinion and commentary
ISSN: 1056-2036
Year: 2005
General services, Safety and security measures, Beliefs, opinions and attitudes, Powers and duties, United States. Food and Drug Administration, Drug approval, Leavitt, Michael

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Schering Case Demonstrates Manipulation Of Drug Prices

Article Abstract:

Schering-Plough Corp. will pay $345.5 million to settle a Medicaid investigation into drug pricing. The company sold drugs to two health insurers for less than it charged Medicare.

Author: Abelson, Reed
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Commodity & service prices, Medicaid, Administration of Public Health Programs, Company legal issue, Cases, Prices and rates, Investigations, Schering-Plough Corp., Price gouging, Company pricing policy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Drugs, Laws, regulations and rules, Pharmaceutical industry, Government regulation
Similar abstracts:
  • Abstracts: Hollinger narrows scope of asset sales: Focus now on selling British publications. Daimler shares hit by warning
  • Abstracts: Canada Life meeting promises to be unruly. Canadian construction continues to rise. Venture capital investing pace slows
  • Abstracts: Hollinger board scheduled to meet. Hollinger shares plummet on reports
  • Abstracts: OSC widens market-timing probe. Accounting hearing is told misconduct charges against auditors are 'rubbish'
  • Abstracts: SNC building on strong foundation, but analysts query remaining upside
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.